KRAS and neoplasm: Consistent with the GSEA data, KRAS was preferentially expressed in the edge tumor cells and both c-Myc and CHEK1 were present in the core regions (Fig. 2b), To further validate these results, we developed another model by using slice cultures of neonatal mouse brains.